Northern Trust’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.84M Buy
445,067
+296,265
+199% +$1.89M ﹤0.01% 2795
2025
Q1
$723K Buy
148,802
+2,913
+2% +$14.2K ﹤0.01% 3414
2024
Q4
$1.39M Buy
145,889
+3,692
+3% +$35.3K ﹤0.01% 3223
2024
Q3
$1.19M Sell
142,197
-289,023
-67% -$2.41M ﹤0.01% 3282
2024
Q2
$2.94M Sell
431,220
-16,380
-4% -$112K ﹤0.01% 2691
2024
Q1
$1.13M Sell
447,600
-3,882
-0.9% -$9.82K ﹤0.01% 3259
2023
Q4
$1.08M Sell
451,482
-36,871
-8% -$88.5K ﹤0.01% 3288
2023
Q3
$1.66M Sell
488,353
-44,742
-8% -$152K ﹤0.01% 3040
2023
Q2
$3.92M Sell
533,095
-2,202
-0.4% -$16.2K ﹤0.01% 2639
2023
Q1
$5.55M Sell
535,297
-297,565
-36% -$3.08M ﹤0.01% 2401
2022
Q4
$9.84M Sell
832,862
-9,268
-1% -$109K ﹤0.01% 2020
2022
Q3
$17.7M Buy
842,130
+241,812
+40% +$5.08M ﹤0.01% 1579
2022
Q2
$18.6M Sell
600,318
-15,714
-3% -$488K ﹤0.01% 1570
2022
Q1
$25.3M Buy
616,032
+59,261
+11% +$2.43M ﹤0.01% 1512
2021
Q4
$24.2M Sell
556,771
-363,963
-40% -$15.8M ﹤0.01% 1633
2021
Q3
$46.1M Sell
920,734
-19,999
-2% -$1M 0.01% 1140
2021
Q2
$59.3M Buy
940,733
+168,302
+22% +$10.6M 0.01% 997
2021
Q1
$71.8M Sell
772,431
-30,905
-4% -$2.87M 0.01% 852
2020
Q4
$72M Buy
803,336
+4,640
+0.6% +$416K 0.01% 826
2020
Q3
$82.5M Buy
798,696
+35,341
+5% +$3.65M 0.02% 644
2020
Q2
$60.4M Sell
763,355
-298,319
-28% -$23.6M 0.01% 757
2020
Q1
$61.4M Buy
1,061,674
+27,082
+3% +$1.57M 0.02% 668
2019
Q4
$55.8M Sell
1,034,592
-33,705
-3% -$1.82M 0.01% 942
2019
Q3
$55.9M Buy
1,068,297
+66,878
+7% +$3.5M 0.01% 885
2019
Q2
$48.4M Buy
1,001,419
+98,858
+11% +$4.78M 0.01% 1031
2019
Q1
$45.6M Buy
902,561
+35,991
+4% +$1.82M 0.01% 1040
2018
Q4
$51.4M Sell
866,570
-107,466
-11% -$6.37M 0.01% 832
2018
Q3
$64.1M Sell
974,036
-176,148
-15% -$11.6M 0.02% 806
2018
Q2
$58.1M Buy
1,150,184
+117,098
+11% +$5.91M 0.01% 875
2018
Q1
$54.4M Sell
1,033,086
-646
-0.1% -$34K 0.01% 928
2017
Q4
$48M Sell
1,033,732
-7,653
-0.7% -$356K 0.01% 1005
2017
Q3
$42.1M Buy
1,041,385
+134,654
+15% +$5.45M 0.01% 1094
2017
Q2
$30.7M Buy
906,731
+290,863
+47% +$9.86M 0.01% 1345
2017
Q1
$17.9M Buy
615,868
+18,462
+3% +$536K 0.01% 1713
2016
Q4
$19.6M Buy
597,406
+46,757
+8% +$1.54M 0.01% 1628
2016
Q3
$17.4M Buy
550,649
+15,851
+3% +$500K 0.01% 1699
2016
Q2
$15M Buy
534,798
+41,139
+8% +$1.16M ﹤0.01% 1738
2016
Q1
$17.9M Buy
493,659
+8,636
+2% +$314K 0.01% 1571
2015
Q4
$19.4M Sell
485,023
-6,425
-1% -$257K 0.01% 1534
2015
Q3
$14M Buy
491,448
+74,593
+18% +$2.13M ﹤0.01% 1751
2015
Q2
$13.7M Buy
416,855
+57,352
+16% +$1.89M ﹤0.01% 1855
2015
Q1
$10.3M Buy
359,503
+10,402
+3% +$299K ﹤0.01% 2061
2014
Q4
$9.51M Sell
349,101
-8,851
-2% -$241K ﹤0.01% 2074
2014
Q3
$7.63M Buy
357,952
+1,938
+0.5% +$41.3K ﹤0.01% 2226
2014
Q2
$8M Sell
356,014
-38,760
-10% -$871K ﹤0.01% 2199
2014
Q1
$9.98M Sell
394,774
-28,470
-7% -$719K ﹤0.01% 2107
2013
Q4
$9.73M Sell
423,244
-4,427
-1% -$102K ﹤0.01% 2108
2013
Q3
$8.15M Buy
427,671
+5,895
+1% +$112K ﹤0.01% 2170
2013
Q2
$6.08M Buy
+421,776
New +$6.08M ﹤0.01% 2282